FdaApplication
ANDA 206506
Identifiers
- fda_app_no: ANDA206506
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | ANDA |
| approval_date | 2019-02-06 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 100MG/10ML (10MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| NALBUPHINE HYDROCHLORIDE | NALBUPHINE HYDROCHLORIDE | 200MG/10ML (20MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
2 products